SHIRE PLC: Total Voting Rights

Total Voting Rights 
August 1, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in
accordance with the Financial Conduct Authority's (the "FCA") Disclosure and
Transparency Rule 5.6.1R, notifies the market of the following: 
At close of business on July 31, 2013, the Company's issued ordinary share
capital comprised 553,280,952 ordinary shares of 5 pence each with voting
rights and a further 9,583,490 ordinary shares held in treasury. 
Therefore the total number of voting rights in the Company is 553,280,952. This
is the figure which should be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure and Transparency Rules. 
Tony Guthrie
Deputy Company Secretary 
For further information please contact: 
Investor Relations                                                              
Eric Rojas                         +1 781 482 0999    
Sarah Elton-Farr               +44 1256 894157    
Notes to editors 
Shire enables people with life-altering conditions to lead better lives. 
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs. 
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,
Internal Medicine and Regenerative Medicine and we are developing treatments
for symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas. 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX 
Press Release                                      
-0- Aug/01/2013 11:00 GMT
Press spacebar to pause and continue. Press esc to stop.